Начало › Колоректален рак › Мичиган › Ann Arbor
Клинични проучвания за Колоректален рак в Ann Arbor, MI
23 проучвания за Колоректален рак търсят участници в обекти в и около Ann Arbor (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Набиране на участници
- University of Michigan Health, Ann Arbor
Family Communications After Genetic Testing
Набиране на участнициЗдравите доброволци са добре дошли
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- и още 4
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Набиране на участнициФаза 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Chelsea Hospital, Chelsea · на 15 мили
- и още 3
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- и още 4
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Набиране на участнициФаза 1/2
- University of Michigan, Ann Arbor
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 2
- University Of Michigan /ID# 270790, Ann Arbor
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Набиране на участнициФаза 3
- University of Michigan Rogel Cancer Center, Ann Arbor
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Набиране на участнициФаза 1/2
- University of Michigan Health System, Ann Arbor
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Набиране на участнициФаза 3
- VA Ann Arbor Healthcare System, Ann Arbor
- University of Michigan, Ann Arbor
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- University of Michigan, Ann Arbor
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Набиране на участнициФаза 3
- University of Michigan Rogel Cancer Center, Ann Arbor
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Набиране на участнициФаза 2/3
- Local Institution - 0430, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Набиране на участнициФаза 1/2
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Набиране на участнициФаза 3
- Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Набиране на участнициФаза 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Набиране на участнициФаза 1/2
- C S Mott Children's Hospital, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Набиране на участнициФаза 2
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- University of Michigan, Ann Arbor
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Набиране на участнициНаблюдателно проучване
- University of Michigan, Ann Arbor
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Набиране на участнициФаза 3Здравите доброволци са добре дошли
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · на 7 мили
- и още 5
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Набиране на участници
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Набиране на участнициНаблюдателно проучване
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology -Ann Arbor, Ypsilanti · на 7 мили
- Chelsea Hospital, Chelsea · на 15 мили
- и още 3
Проучвания за Колоректален рак в други градове
- Houston, TX102 проучвания
- New York City, NY78 проучвания
- Nashville, TN69 проучвания
- Boston, MA63 проучвания
- Los Angeles, CA59 проучвания
- Arlington, VA52 проучвания
- St. Louis, MO50 проучвания
- San Antonio, TX46 проучвания
- Philadelphia, PA44 проучвания
- Grand Rapids, MI40 проучвания
- Baldwin Park, CA37 проучвания
- Chicago, IL34 проучвания
Други проучвания в Ann Arbor
- Рак на гърдата27 проучвания
- Рак на простатата27 проучвания
- Рак на белия дроб с недребноклетъчен тип26 проучвания
- Рак (всички видове)25 проучвания
- Рак на белия дроб23 проучвания
- Сърдечна недостатъчност22 проучвания
- Остра миелоидна левкемия17 проучвания
- Сърдечно-съдово заболяване16 проучвания
- Рак на панкреаса14 проучвания
- Меланом12 проучвания
- Инсульт12 проучвания
- Плоскоклетъчен карцином на главата и шията12 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.